tradingkey.logo

Mangoceuticals Inc

MGRX
0.713USD
-0.597-45.57%
收盘 12/19, 16:00美东报价延迟15分钟
9.90M总市值
0.01市盈率 TTM

Mangoceuticals Inc

0.713
-0.597-45.57%

关于 Mangoceuticals Inc 公司

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc简介

公司代码MGRX
公司名称Mangoceuticals Inc
上市日期Mar 21, 2023
CEOCohen (Jacob D)
员工数量- -
证券类型Ordinary Share
年结日Mar 21
公司地址15110 Dallas Pkwy, Suite 600
城市DALLAS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编75248
电话18336264679
网址https://www.mangorx.com/
公司代码MGRX
上市日期Mar 21, 2023
CEOCohen (Jacob D)

Mangoceuticals Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
128.33K
-7.23%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
1.67K
-98.68%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
128.33K
-7.23%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
1.67K
-98.68%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月21日 周五
更新时间: 11月21日 周五
持股股东
股东类型
持股股东
持股股东
占比
Cohen (Jacob D.)
8.48%
Navy Wharf, Ltd.
6.50%
Propre Energie Inc
4.22%
Greenfield Investments Ltd
3.35%
The Vanguard Group, Inc.
1.25%
其他
76.20%
持股股东
持股股东
占比
Cohen (Jacob D.)
8.48%
Navy Wharf, Ltd.
6.50%
Propre Energie Inc
4.22%
Greenfield Investments Ltd
3.35%
The Vanguard Group, Inc.
1.25%
其他
76.20%
股东类型
持股股东
占比
Corporation
15.57%
Individual Investor
12.74%
Investment Advisor
1.71%
Investment Advisor/Hedge Fund
0.77%
Venture Capital
0.20%
其他
69.00%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
27
301.64K
2.21%
-28.95K
2025Q2
38
3.44M
29.63%
+1.40M
2025Q1
35
1.92M
37.79%
+1.11M
2024Q4
34
1.29M
45.58%
-18.06K
2024Q3
32
811.21K
40.72%
-490.52K
2024Q2
27
759.36K
45.89%
-544.02K
2024Q1
26
674.02K
59.33%
-527.17K
2023Q4
22
660.62K
58.15%
-532.64K
2023Q3
19
652.27K
63.81%
+112.43K
2023Q2
12
649.40K
63.58%
+115.75K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Cohen (Jacob D.)
1.30M
12.39%
+500.00K
+62.11%
Jul 21, 2025
Navy Wharf, Ltd.
1.00M
9.49%
+1.00M
--
May 27, 2025
Propre Energie Inc
650.00K
6.17%
--
--
May 27, 2025
Greenfield Investments Ltd
515.00K
4.89%
--
--
May 27, 2025
The Vanguard Group, Inc.
182.61K
1.73%
+182.61K
--
Jun 30, 2025
Myers (Kenny)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
D'Alessio (Lorraine Pamela)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
Johnston (Eugene M)
138.33K
1.31%
+100.00K
+260.87%
Sep 09, 2025
Geode Capital Management, L.L.C.
26.50K
0.25%
+6.93K
+35.40%
Jun 30, 2025
Isaac (Antonios)
60.00K
0.57%
--
--
May 27, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
公告日期
类型
比率
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1

常见问题

Mangoceuticals Inc的前五大股东是谁?

Mangoceuticals Inc 的前五大股东如下:
Cohen (Jacob D.)持有股份:1.30M,占总股份比例:12.39%。
Navy Wharf, Ltd.持有股份:1.00M,占总股份比例:9.49%。
Propre Energie Inc持有股份:650.00K,占总股份比例:6.17%。
Greenfield Investments Ltd持有股份:515.00K,占总股份比例:4.89%。
The Vanguard Group, Inc.持有股份:182.61K,占总股份比例:1.73%。

Mangoceuticals Inc的前三大股东类型是什么?

Mangoceuticals Inc 的前三大股东类型分别是:
Cohen (Jacob D.)
Navy Wharf, Ltd.
Propre Energie Inc

有多少机构持有Mangoceuticals Inc(MGRX)的股份?

截至2025Q3,共有27家机构持有Mangoceuticals Inc的股份,合计持有的股份价值约为301.64K,占公司总股份的2.21%。与2025Q2相比,机构持股有所增加,增幅为-27.42%。

哪个业务部门对Mangoceuticals Inc的收入贡献最大?

在--,--业务部门对Mangoceuticals Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI